南韓擬對已接種疫苗人士實施入境免隔離措施
《韓聯社》報道,南韓疾病管理廳廳長鄭銀敬今日(28日)在記者會上表示,正討論針對完成新冠疫苗全程接種的入境人士實施入境免隔離措施。
鄭銀敬表示,在Omicron流行初期,通過對入境人士實施隔離措施得以最大程度地推遲Omicron在境內蔓延。南韓目前針對入境人士試點實施檢查疫苗接種史、核酸陰性證明、健康狀況的「事前入境申報」措施,將探討基於個人感染風險變更入境人員管理方式的方案,並適時實施。
目前,所有境外入境人士無論是否接種均需接受7天隔離,且需出示離境日48小時內的核酸檢測陰性證明,並在入境首日和隔離解除前一日再次接受核酸檢測。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.